Global Socially Stigmatized Diseases Market 2024-2028

Socially Stigmatized Diseases Market 2024-2028


The socially stigmatized diseases market is forecasted to grow by USD 343.5 bn during 2023-2028, accelerating at a CAGR of 8.2% during the forecast period. The report on the socially stigmatized diseases market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by high prevalence of hiv, high prevalence of cancer, and high incidence of mental health disorders.

Technavio's socially stigmatized diseases market is segmented as below:

By Disease Type
  • STIs
  • Mental health disorders
  • Cancer
  • Others
By Therapy
  • Medications
  • Therapy and counseling
  • Others
By Geographical Landscape
  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the availability of hiv medication online as one of the prime reasons driving the socially stigmatized diseases market growth during the next few years. Also, proliferation of generics and initiation of mental health campaigns will lead to sizable demand in the market.

The report on the socially stigmatized diseases market covers the following areas:
  • Socially Stigmatized Diseases Market sizing
  • Socially Stigmatized Diseases Market forecast
  • Socially Stigmatized Diseases Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading socially stigmatized diseases market vendors that include AbbVie Inc., Aurobindo Pharma Ltd., Bristol Myers Squibb Co., Cipla Inc., Dr Reddys Laboratories Ltd., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Johnson and Johnson Inc., Lupin Ltd., Merck and Co. Inc., Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., Viatris Inc., and ViiV Healthcare. Also, the socially stigmatized diseases market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.


1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Disease Type
Executive Summary - Chart on Market Segmentation by Therapy
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
Overview on factors of disruption
2.4 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
3 Market Landscape
3.1 Market ecosystem
Parent Market
Data Table on - Parent Market
3.2 Market characteristics
Market characteristics analysis
3.3 Value chain analysis
Value Chain Analysis
4 Market Sizing
4.1 Market definition
Offerings of companies included in the market definition
4.2 Market segment analysis
Market segments
4.3 Market size 2023
4.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ billion)
Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)
5 Historic Market Size
5.1 Global Socially Stigmatized Diseases Market 2018 - 2022
Historic Market Size - Data Table on Global Socially Stigmatized Diseases Market 2018 - 2022 ($ billion)
5.2 Disease Type segment analysis 2018 - 2022
Historic Market Size - Disease Type Segment 2018 - 2022 ($ billion)
5.3 Therapy segment analysis 2018 - 2022
Historic Market Size - Therapy Segment 2018 - 2022 ($ billion)
5.4 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
5.5 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ billion)
6 Qualitative Analysis
6.1 Impact of AI on global stigmatized diseases market
7 Five Forces Analysis
7.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
7.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
7.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
7.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
7.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
7.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
7.7 Market condition
Chart on Market condition - Five forces 2023 and 2028
8 Market Segmentation by Disease Type
8.1 Market segments
Chart on Disease Type - Market share 2023-2028 (%)
Data Table on Disease Type - Market share 2023-2028 (%)
8.2 Comparison by Disease Type
Chart on Comparison by Disease Type
Data Table on Comparison by Disease Type
8.3 STIs - Market size and forecast 2023-2028
Chart on STIs - Market size and forecast 2023-2028 ($ billion)
Data Table on STIs - Market size and forecast 2023-2028 ($ billion)
Chart on STIs - Year-over-year growth 2023-2028 (%)
Data Table on STIs - Year-over-year growth 2023-2028 (%)
8.4 Mental health disorders - Market size and forecast 2023-2028
Chart on Mental health disorders - Market size and forecast 2023-2028 ($ billion)
Data Table on Mental health disorders - Market size and forecast 2023-2028 ($ billion)
Chart on Mental health disorders - Year-over-year growth 2023-2028 (%)
Data Table on Mental health disorders - Year-over-year growth 2023-2028 (%)
8.5 Cancer - Market size and forecast 2023-2028
Chart on Cancer - Market size and forecast 2023-2028 ($ billion)
Data Table on Cancer - Market size and forecast 2023-2028 ($ billion)
Chart on Cancer - Year-over-year growth 2023-2028 (%)
Data Table on Cancer - Year-over-year growth 2023-2028 (%)
8.6 Others - Market size and forecast 2023-2028
Chart on Others - Market size and forecast 2023-2028 ($ billion)
Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Chart on Others - Year-over-year growth 2023-2028 (%)
Data Table on Others - Year-over-year growth 2023-2028 (%)
8.7 Market opportunity by Disease Type
Market opportunity by Disease Type ($ billion)
Data Table on Market opportunity by Disease Type ($ billion)
9 Market Segmentation by Therapy
9.1 Market segments
Chart on Therapy - Market share 2023-2028 (%)
Data Table on Therapy - Market share 2023-2028 (%)
9.2 Comparison by Therapy
Chart on Comparison by Therapy
Data Table on Comparison by Therapy
9.3 Medications - Market size and forecast 2023-2028
Chart on Medications - Market size and forecast 2023-2028 ($ billion)
Data Table on Medications - Market size and forecast 2023-2028 ($ billion)
Chart on Medications - Year-over-year growth 2023-2028 (%)
Data Table on Medications - Year-over-year growth 2023-2028 (%)
9.4 Therapy and counseling - Market size and forecast 2023-2028
Chart on Therapy and counseling - Market size and forecast 2023-2028 ($ billion)
Data Table on Therapy and counseling - Market size and forecast 2023-2028 ($ billion)
Chart on Therapy and counseling - Year-over-year growth 2023-2028 (%)
Data Table on Therapy and counseling - Year-over-year growth 2023-2028 (%)
9.5 Others - Market size and forecast 2023-2028
Chart on Others - Market size and forecast 2023-2028 ($ billion)
Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Chart on Others - Year-over-year growth 2023-2028 (%)
Data Table on Others - Year-over-year growth 2023-2028 (%)
9.6 Market opportunity by Therapy
Market opportunity by Therapy ($ billion)
Data Table on Market opportunity by Therapy ($ billion)
10 Customer Landscape
10.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
11 Geographic Landscape
11.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2023-2028 (%)
Data Table on Market share By Geographical Landscape 2023-2028 (%)
11.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
11.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ billion)
Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
11.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
11.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
11.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
11.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ billion)
Data Table on US - Market size and forecast 2023-2028 ($ billion)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
11.8 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ billion)
Data Table on China - Market size and forecast 2023-2028 ($ billion)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
11.9 Japan - Market size and forecast 2023-2028
Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Chart on Japan - Year-over-year growth 2023-2028 (%)
Data Table on Japan - Year-over-year growth 2023-2028 (%)
11.10 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
11.11 India - Market size and forecast 2023-2028
Chart on India - Market size and forecast 2023-2028 ($ billion)
Data Table on India - Market size and forecast 2023-2028 ($ billion)
Chart on India - Year-over-year growth 2023-2028 (%)
Data Table on India - Year-over-year growth 2023-2028 (%)
11.12 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ billion)
Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
11.13 France - Market size and forecast 2023-2028
Chart on France - Market size and forecast 2023-2028 ($ billion)
Data Table on France - Market size and forecast 2023-2028 ($ billion)
Chart on France - Year-over-year growth 2023-2028 (%)
Data Table on France - Year-over-year growth 2023-2028 (%)
11.14 South Korea - Market size and forecast 2023-2028
Chart on South Korea - Market size and forecast 2023-2028 ($ billion)
Data Table on South Korea - Market size and forecast 2023-2028 ($ billion)
Chart on South Korea - Year-over-year growth 2023-2028 (%)
Data Table on South Korea - Year-over-year growth 2023-2028 (%)
11.15 Italy - Market size and forecast 2023-2028
Chart on Italy - Market size and forecast 2023-2028 ($ billion)
Data Table on Italy - Market size and forecast 2023-2028 ($ billion)
Chart on Italy - Year-over-year growth 2023-2028 (%)
Data Table on Italy - Year-over-year growth 2023-2028 (%)
11.16 Canada - Market size and forecast 2023-2028
Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Chart on Canada - Year-over-year growth 2023-2028 (%)
Data Table on Canada - Year-over-year growth 2023-2028 (%)
11.17 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ billion)
Data Tables on Market opportunity By Geographical Landscape ($ billion)
12 Drivers, Challenges, and Opportunity/Restraints
12.1 Market drivers
12.2 Market challenges
12.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
12.4 Market opportunities/restraints
13 Competitive Landscape
13.1 Overview
13.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
13.3 Landscape disruption
Overview on factors of disruption
13.4 Industry risks
Impact of key risks on business
14 Competitive Analysis
14.1 Companies profiled
Companies covered
14.2 Company ranking index
Company ranking index
14.3 Market positioning of companies
Matrix on companies position and classification
14.4 AbbVie Inc.
AbbVie Inc. - Overview
AbbVie Inc. - Product / Service
AbbVie Inc. - Key news
AbbVie Inc. - Key offerings
SWOT
14.5 Aurobindo Pharma Ltd.
Aurobindo Pharma Ltd. - Overview
Aurobindo Pharma Ltd. - Product / Service
Aurobindo Pharma Ltd. - Key offerings
SWOT
14.6 Bristol Myers Squibb Co.
Bristol Myers Squibb Co. - Overview
Bristol Myers Squibb Co. - Product / Service
Bristol Myers Squibb Co. - Key news
Bristol Myers Squibb Co. - Key offerings
SWOT
14.7 Cipla Inc.
Cipla Inc. - Overview
Cipla Inc. - Business segments
Cipla Inc. - Key news
Cipla Inc. - Key offerings
Cipla Inc. - Segment focus
SWOT
14.8 Dr Reddys Laboratories Ltd.
Dr Reddys Laboratories Ltd. - Overview
Dr Reddys Laboratories Ltd. - Business segments
Dr Reddys Laboratories Ltd. - Key news
Dr Reddys Laboratories Ltd. - Key offerings
Dr Reddys Laboratories Ltd. - Segment focus
SWOT
14.9 F. Hoffmann La Roche Ltd.
F. Hoffmann La Roche Ltd. - Overview
F. Hoffmann La Roche Ltd. - Business segments
F. Hoffmann La Roche Ltd. - Key news
F. Hoffmann La Roche Ltd. - Key offerings
F. Hoffmann La Roche Ltd. - Segment focus
SWOT
14.10 Gilead Sciences Inc.
Gilead Sciences Inc. - Overview
Gilead Sciences Inc. - Product / Service
Gilead Sciences Inc. - Key news
Gilead Sciences Inc. - Key offerings
SWOT
14.11 GlaxoSmithKline Plc
GlaxoSmithKline Plc - Overview
GlaxoSmithKline Plc - Business segments
GlaxoSmithKline Plc - Key news
GlaxoSmithKline Plc - Key offerings
GlaxoSmithKline Plc - Segment focus
SWOT
14.12 Johnson and Johnson Inc.
Johnson and Johnson Inc. - Overview
Johnson and Johnson Inc. - Business segments
Johnson and Johnson Inc. - Key news
Johnson and Johnson Inc. - Key offerings
Johnson and Johnson Inc. - Segment focus
SWOT
14.13 Merck and Co. Inc.
Merck and Co. Inc. - Overview
Merck and Co. Inc. - Business segments
Merck and Co. Inc. - Key news
Merck and Co. Inc. - Key offerings
Merck and Co. Inc. - Segment focus
SWOT
14.14 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
SWOT
14.15 Sanofi SA
Sanofi SA - Overview
Sanofi SA - Business segments
Sanofi SA - Key news
Sanofi SA - Key offerings
Sanofi SA - Segment focus
SWOT
14.16 Sun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries Ltd. - Overview
Sun Pharmaceutical Industries Ltd. - Product / Service
Sun Pharmaceutical Industries Ltd. - Key news
Sun Pharmaceutical Industries Ltd. - Key offerings
SWOT
14.17 Viatris Inc.
Viatris Inc. - Overview
Viatris Inc. - Business segments
Viatris Inc. - Key news
Viatris Inc. - Key offerings
Viatris Inc. - Segment focus
SWOT
14.18 ViiV Healthcare
ViiV Healthcare - Overview
ViiV Healthcare - Product / Service
ViiV Healthcare - Key offerings
SWOT
15 Appendix
15.1 Scope of the report
15.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
15.3 Currency conversion rates for US$
Currency conversion rates for US$
15.4 Research methodology
Research methodology
15.5 Data procurement
Information sources
15.6 Data validation
Data validation
15.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
15.8 Data synthesis
Data synthesis
15.9 360 degree market analysis
360 degree market analysis
15.10 List of abbreviations
List of abbreviations
Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Disease Type
Exhibits6: Executive Summary - Chart on Market Segmentation by Therapy
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Company Market Positioning
Exhibits10: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits11: Overview on criticality of inputs and factors of differentiation
Exhibits12: Overview on factors of disruption
Exhibits13: Impact of drivers and challenges in 2023 and 2028
Exhibits14: Parent Market
Exhibits15: Data Table on - Parent Market
Exhibits16: Market characteristics analysis
Exhibits17: Value Chain Analysis
Exhibits18: Offerings of companies included in the market definition
Exhibits19: Market segments
Exhibits20: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits21: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits22: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits23: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits24: Historic Market Size - Data Table on Global Socially Stigmatized Diseases Market 2018 - 2022 ($ billion)
Exhibits25: Historic Market Size - Disease Type Segment 2018 - 2022 ($ billion)
Exhibits26: Historic Market Size - Therapy Segment 2018 - 2022 ($ billion)
Exhibits27: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits28: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits29: Five forces analysis - Comparison between 2023 and 2028
Exhibits30: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits31: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits32: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits33: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits34: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits35: Chart on Market condition - Five forces 2023 and 2028
Exhibits36: Chart on Disease Type - Market share 2023-2028 (%)
Exhibits37: Data Table on Disease Type - Market share 2023-2028 (%)
Exhibits38: Chart on Comparison by Disease Type
Exhibits39: Data Table on Comparison by Disease Type
Exhibits40: Chart on STIs - Market size and forecast 2023-2028 ($ billion)
Exhibits41: Data Table on STIs - Market size and forecast 2023-2028 ($ billion)
Exhibits42: Chart on STIs - Year-over-year growth 2023-2028 (%)
Exhibits43: Data Table on STIs - Year-over-year growth 2023-2028 (%)
Exhibits44: Chart on Mental health disorders - Market size and forecast 2023-2028 ($ billion)
Exhibits45: Data Table on Mental health disorders - Market size and forecast 2023-2028 ($ billion)
Exhibits46: Chart on Mental health disorders - Year-over-year growth 2023-2028 (%)
Exhibits47: Data Table on Mental health disorders - Year-over-year growth 2023-2028 (%)
Exhibits48: Chart on Cancer - Market size and forecast 2023-2028 ($ billion)
Exhibits49: Data Table on Cancer - Market size and forecast 2023-2028 ($ billion)
Exhibits50: Chart on Cancer - Year-over-year growth 2023-2028 (%)
Exhibits51: Data Table on Cancer - Year-over-year growth 2023-2028 (%)
Exhibits52: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits53: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits54: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits56: Market opportunity by Disease Type ($ billion)
Exhibits57: Data Table on Market opportunity by Disease Type ($ billion)
Exhibits58: Chart on Therapy - Market share 2023-2028 (%)
Exhibits59: Data Table on Therapy - Market share 2023-2028 (%)
Exhibits60: Chart on Comparison by Therapy
Exhibits61: Data Table on Comparison by Therapy
Exhibits62: Chart on Medications - Market size and forecast 2023-2028 ($ billion)
Exhibits63: Data Table on Medications - Market size and forecast 2023-2028 ($ billion)
Exhibits64: Chart on Medications - Year-over-year growth 2023-2028 (%)
Exhibits65: Data Table on Medications - Year-over-year growth 2023-2028 (%)
Exhibits66: Chart on Therapy and counseling - Market size and forecast 2023-2028 ($ billion)
Exhibits67: Data Table on Therapy and counseling - Market size and forecast 2023-2028 ($ billion)
Exhibits68: Chart on Therapy and counseling - Year-over-year growth 2023-2028 (%)
Exhibits69: Data Table on Therapy and counseling - Year-over-year growth 2023-2028 (%)
Exhibits70: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits71: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits72: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits73: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits74: Market opportunity by Therapy ($ billion)
Exhibits75: Data Table on Market opportunity by Therapy ($ billion)
Exhibits76: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits77: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits78: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits79: Chart on Geographic comparison
Exhibits80: Data Table on Geographic comparison
Exhibits81: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits82: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits83: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits84: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits85: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits86: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits87: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits88: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits89: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits90: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits91: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits92: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits93: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits94: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits95: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits96: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits97: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits98: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits99: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits100: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits101: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits102: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits103: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits104: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits105: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits106: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits107: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits108: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits109: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits110: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits111: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits112: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits113: Chart on India - Market size and forecast 2023-2028 ($ billion)
Exhibits114: Data Table on India - Market size and forecast 2023-2028 ($ billion)
Exhibits115: Chart on India - Year-over-year growth 2023-2028 (%)
Exhibits116: Data Table on India - Year-over-year growth 2023-2028 (%)
Exhibits117: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits118: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits119: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits120: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits121: Chart on France - Market size and forecast 2023-2028 ($ billion)
Exhibits122: Data Table on France - Market size and forecast 2023-2028 ($ billion)
Exhibits123: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibits124: Data Table on France - Year-over-year growth 2023-2028 (%)
Exhibits125: Chart on South Korea - Market size and forecast 2023-2028 ($ billion)
Exhibits126: Data Table on South Korea - Market size and forecast 2023-2028 ($ billion)
Exhibits127: Chart on South Korea - Year-over-year growth 2023-2028 (%)
Exhibits128: Data Table on South Korea - Year-over-year growth 2023-2028 (%)
Exhibits129: Chart on Italy - Market size and forecast 2023-2028 ($ billion)
Exhibits130: Data Table on Italy - Market size and forecast 2023-2028 ($ billion)
Exhibits131: Chart on Italy - Year-over-year growth 2023-2028 (%)
Exhibits132: Data Table on Italy - Year-over-year growth 2023-2028 (%)
Exhibits133: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits134: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits135: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits136: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits137: Market opportunity By Geographical Landscape ($ billion)
Exhibits138: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits139: Impact of drivers and challenges in 2023 and 2028
Exhibits140: Overview on criticality of inputs and factors of differentiation
Exhibits141: Overview on factors of disruption
Exhibits142: Impact of key risks on business
Exhibits143: Companies covered
Exhibits144: Company ranking index
Exhibits145: Matrix on companies position and classification
Exhibits146: AbbVie Inc. - Overview
Exhibits147: AbbVie Inc. - Product / Service
Exhibits148: AbbVie Inc. - Key news
Exhibits149: AbbVie Inc. - Key offerings
Exhibits150: SWOT
Exhibits151: Aurobindo Pharma Ltd. - Overview
Exhibits152: Aurobindo Pharma Ltd. - Product / Service
Exhibits153: Aurobindo Pharma Ltd. - Key offerings
Exhibits154: SWOT
Exhibits155: Bristol Myers Squibb Co. - Overview
Exhibits156: Bristol Myers Squibb Co. - Product / Service
Exhibits157: Bristol Myers Squibb Co. - Key news
Exhibits158: Bristol Myers Squibb Co. - Key offerings
Exhibits159: SWOT
Exhibits160: Cipla Inc. - Overview
Exhibits161: Cipla Inc. - Business segments
Exhibits162: Cipla Inc. - Key news
Exhibits163: Cipla Inc. - Key offerings
Exhibits164: Cipla Inc. - Segment focus
Exhibits165: SWOT
Exhibits166: Dr Reddys Laboratories Ltd. - Overview
Exhibits167: Dr Reddys Laboratories Ltd. - Business segments
Exhibits168: Dr Reddys Laboratories Ltd. - Key news
Exhibits169: Dr Reddys Laboratories Ltd. - Key offerings
Exhibits170: Dr Reddys Laboratories Ltd. - Segment focus
Exhibits171: SWOT
Exhibits172: F. Hoffmann La Roche Ltd. - Overview
Exhibits173: F. Hoffmann La Roche Ltd. - Business segments
Exhibits174: F. Hoffmann La Roche Ltd. - Key news
Exhibits175: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits176: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits177: SWOT
Exhibits178: Gilead Sciences Inc. - Overview
Exhibits179: Gilead Sciences Inc. - Product / Service
Exhibits180: Gilead Sciences Inc. - Key news
Exhibits181: Gilead Sciences Inc. - Key offerings
Exhibits182: SWOT
Exhibits183: GlaxoSmithKline Plc - Overview
Exhibits184: GlaxoSmithKline Plc - Business segments
Exhibits185: GlaxoSmithKline Plc - Key news
Exhibits186: GlaxoSmithKline Plc - Key offerings
Exhibits187: GlaxoSmithKline Plc - Segment focus
Exhibits188: SWOT
Exhibits189: Johnson and Johnson Inc. - Overview
Exhibits190: Johnson and Johnson Inc. - Business segments
Exhibits191: Johnson and Johnson Inc. - Key news
Exhibits192: Johnson and Johnson Inc. - Key offerings
Exhibits193: Johnson and Johnson Inc. - Segment focus
Exhibits194: SWOT
Exhibits195: Merck and Co. Inc. - Overview
Exhibits196: Merck and Co. Inc. - Business segments
Exhibits197: Merck and Co. Inc. - Key news
Exhibits198: Merck and Co. Inc. - Key offerings
Exhibits199: Merck and Co. Inc. - Segment focus
Exhibits200: SWOT
Exhibits201: Pfizer Inc. - Overview
Exhibits202: Pfizer Inc. - Product / Service
Exhibits203: Pfizer Inc. - Key news
Exhibits204: Pfizer Inc. - Key offerings
Exhibits205: SWOT
Exhibits206: Sanofi SA - Overview
Exhibits207: Sanofi SA - Business segments
Exhibits208: Sanofi SA - Key news
Exhibits209: Sanofi SA - Key offerings
Exhibits210: Sanofi SA - Segment focus
Exhibits211: SWOT
Exhibits212: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits213: Sun Pharmaceutical Industries Ltd. - Product / Service

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings